ACI's FCPA and Anti-Corruption for the Life Sciences Industry
FCPA and Anti-Corruption for the Life Sciences IndustryTuesday, May 14 to Wednesday, May 15, 2013ONE UN New York Hotel, New York, NY
The government has made it clear that life sciences companies are under a microscope, and the FCPA and anti-corruption prosecutions will keep coming. Attend the leading anti-corruption conference dedicated the unique issues facing life sciences companies and gain advanced industry-specific strategies to bulletproof already-robust FCPA compliance plans.
In 2012, federal and international enforcement authorities have aggressively continued their pursuit of biopharmaceutical and medical device companies for FCPA and anti-corruption violations, resulting in high profile investigations and record-breaking fines and settlements. In response to the challenges facing biopharmaceutical and medical device companies in this daunting climate as the life sciences industry sweep continues, the 7th Advanced Forum on FCPA & Anti-Corruption for the Life Sciences Industry provides a forum for the key players- top prosecutors, preeminent corporate counsel, and leading FCPA practitioners- to come together to give you a specific action plan to bolster your anti-corruption compliance regime and combat the next wave of FCPA allegations.
Paul Hastings partner Nathaniel Edmonds is a featured panelist on Day One, May 14, at 8:45 am to discuss "Strengthening Compliance Post-FCPA Guidance and Life Sciences Enforcement Sweep: Core Components of a Robust Anti-Corruption Program and Lessons Learned from the Most Costly Mistakes."